Dexcom G7 sensors
Ended Awarded
- Contract number
- SPE2DR26F56CX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,936
Award facts
- Contract value 100% obligated
- $30,935.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30,935.63 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors under a firm fixed-price, competitively awarded contract. The award was issued on November 18, 2025, with an ultimate completion date of November 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery order represents a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.9 billion prime vendor agreement valued through December 2026 that enables the company to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver diverse medical products including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The Dexcom G7 sensors supplied under this delivery order support diabetes management for Department of Defense beneficiaries. As a non-set-aside award, this contract reflects AmerisourceBergen's ability to compete successfully in open federal procurement processes and fulfill the government's ongoing medical supply requirements through its established prime vendor relationship with the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DR26F56CX?
SPE2DR26F56CX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26F56CX worth?
The government has obligated $30,936 on SPE2DR26F56CX.
Is contract SPE2DR26F56CX an order under another contract?
Yes. SPE2DR26F56CX is a delivery order under SPE2DR25D2006, an indefinite delivery contract.
Was contract SPE2DR26F56CX competed?
The extent of competition for SPE2DR26F56CX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award